Amal Therapeutics: Clinical Trials

1 trial sponsored by Amal Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Amal Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
ATP128, BI 754091, VSV-GP128 - Colorectal Cancer, MSS
Phase 1Active not recruitingAmal Therapeutics962019-07-222025-01-29

Conditions studied

Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Rectal Neoplasms (1)

Countries

Belgium (1)  ·  Germany (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Scott Kopetz (1)

Results publications

PMID 38314087

NIH funding

2019 (1)